Fluorescent In Situ Hybridization As a Primary Test for HER2 Status in Breast Cancer: Controversies

被引：4

作者：

Arena, Vincenzo ^{[1
]}

Pennacchia, Ilaria ^{[1
]}

Monego, Giovanni ^{[1
]}

Carbone, Arnaldo ^{[1
]}

Capelli, Arnaldo ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Ist Anat Patol, Rome, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 05期

关键词：

RECEPTOR; 2; ASSESSMENT; CUTOFF; FISH;

D O I：

10.1200/JCO.2009.25.1397

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E83 / E84

页数：2

共 15 条

[1] IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest™ in breast carcinoma [J].

Ainsworth, R ;

Bartlett, JMS ;

Going, JJ ;

Mallon, EA ;

Forsyth, A ;

Richmond, J ;

Angerson, W ;

Watters, A ;

Dunne, B .

JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (10) :1086-1090

[2] Fluorescent In Situ Hybridization for Human Epidermal Growth Factor Receptor 2 Assessment in Breast Cancer: Is It Applicable As a Primary Test? [J].

Arena, Vincenzo ;

Pennacchia, Ilaria ;

Carbone, Arnaldo ;

Capelli, Arnaldo .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) :E8-E8

[3] Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification [J].

Cayre, Anne ;

Mishellany, Florence ;

Lagarde, Nicole ;

Penault-Llorca, Fredirique .

BREAST CANCER RESEARCH, 2007, 9 (05) :R64

[4] Standardization of HER2 testing:: results of an international proficiency-testing ring study [J].

Dowsett, Mitch ;

Hanna, Wedad M. ;

Kockx, Mark ;

Penault-Llorca, Frederique ;

Rueschoff, Josef ;

Gutjahr, Thorsten ;

Habben, Kai ;

van de Vijver, Marc J. .

MODERN PATHOLOGY, 2007, 20 (05) :584-591

[5] Immunohistochemical antibodies in breast cancer HER2 diagnostics [J].

Egervari, Kristof ;

Szollosi, Zoltan ;

Nemes, Zoltan .

TUMOR BIOLOGY, 2008, 29 (01) :18-27

[6] Refinement of immunohistologic parameters for Her2/neu scoring validation by FISH and CISH [J].

Leong, Anthony S-Y ;

Formby, Mark ;

Haffajee, Zenobia ;

Clarke, Megan ;

Morey, Adrienne .

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2006, 14 (04) :384-389

[7]

Middleton LP, 2009, ARCH PATHOL LAB MED, V133, P775, DOI 10.1043/1543-2165-133.5.775

[8] Borderline HER-2 breast cancer cases: Histochemical versus real-time PCR analysis and impact of different cut-off values [J].

Monego, G. ;

Arena, V. ;

Maggiano, N. ;

Costarelli, L. ;

Crescenzi, A. ;

Zelano, G. ;

Amini, M. ;

Capelli, A. ;

Carbone, A. .

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2007, 67 (04) :402-412

[9]

O'Malley FP, 2008, ARCH PATHOL LAB MED, V132, P61, DOI 10.1043/1543-2165(2008)132[61:HTIAPS]2.0.CO

[10]

← 1 2 →